Drug sector performs in bad month

real estate, pharmaceuticals and health sectors performed well across europe during april

Following several years of sustained underperformance, the pharmaceutical sector was one of the best performers across Europe during April, Lipper research has found. This was in a month in which just 296 of the 1,905 UK-domiciled funds posted positive results, and the average return across all products was -2.37% before charges. All IMA equity categories registered falls in average performance in April, with funds invested in the US the worst hit. Smaller companies also suffered a bad month after recent years of outperformance, with the European and UK smaller companies sectors alongsid...